Hyfusin Group to Seek 20% Issue Mandate, 10% Buy-Back Authority and M&A Revamp at 5 June AGM

Hyfusin Group Holdings Limited (Hyfusin Group, 08512) has dispatched a circular dated 23 April 2026 convening its annual general meeting (AGM) for 5 June 2026 in Hong Kong. Key resolutions include refreshed share mandates, board re-elections and a comprehensive update to the company’s constitutional documents.

Mandates on Share Capital • General Issuance: Directors will request authority to allot, issue or deal with up to 20% of the company’s issued share capital (excluding any treasury shares) as at the AGM date. Based on the 918.50 million shares outstanding on the 15 April 2026 latest practicable date, the mandate would cover up to 183.70 million shares. • Share Repurchase: A separate mandate will permit repurchases of up to 10% of issued shares, or 91.85 million shares. Shares bought back may be cancelled or held in treasury under the proposed new Articles. • Extension Option: Subject to both mandates being approved, the board may extend the issuance limit by the number of shares repurchased, potentially raising the effective issuance headroom to 30% of current issued capital.

Governance Matters • Director Elections: Executive Director and CEO Mr Wong Man Chit and Independent Non-Executive Director Mr Ho Chi Wai will retire by rotation and stand for re-election. • Auditor: Re-appointment of BDO Limited and authorisation for directors to fix its remuneration will be voted on. • Constitutional Upgrade: Shareholders will consider adopting a third amended and restated Memorandum & Articles of Association. Key changes introduce explicit provisions for electronic, hybrid and virtual meetings; enable holding of treasury shares; align with the HKEX’s paperless listing framework; and incorporate housekeeping updates.

Key Dates • Register of members closure: 29 May–5 June 2026 (both days inclusive). • Proxy lodgement deadline: 3:00 p.m., 3 June 2026. • Record date for AGM voting: 5 June 2026.

The board emphasises that it has no immediate plans to issue new shares or undertake share buy-backs following approval of the proposed mandates.